Clinical Trials Logo

Filter by:
NCT ID: NCT00495079 Completed - Clinical trials for Acute Lymphoblastic Leukemia (ALL)

Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia

Start date: May 2007
Phase: Phase 2
Study type: Interventional

This was a Phase 2, international, multicenter, open-label, single-arm trial evaluating Marqibo (VSLI) in adult subjects with: 1) Ph- ALL or lymphoblastic lymphoma in second or greater relapse; or 2) Ph- ALL or lymphoblastic lymphoma who failed 2 or greater treatment lines of anti-leukemia chemotherapy. The original enrollment target for this study was approximately 56 subjects. Per a protocol amendment, enrollment was increased from 56 to 65. The primary objective of this study was to evaluate: - The efficacy of the study treatment as determined by the rate of CR plus CR with incomplete blood count recovery (CRi) in adult subjects with Philadelphia chromosome-negative (Ph-) ALL in second relapse or adult subjects with (Ph-) ALL who failed 2 treatment lines of anti-leukemia chemotherapy. Subjects must have achieved a CR to at least 1 prior anti-leukemia therapy as defined by a leukemia-free interval of ≥ 90 days.

NCT ID: NCT00494234 Completed - Breast Neoplasms Clinical Trials

Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer

ICEBERG 1
Start date: June 15, 2007
Phase: Phase 2
Study type: Interventional

The purpose of the study is to see if the drug KU-0059436 (olaparib) is effective and well tolerated in treating participants with measurable breast cancer gene (BRCA)1- or BRCA2-positive advanced breast cancer and for whom no curative therapeutic option exists.

NCT ID: NCT00493740 Recruiting - Clinical trials for Cephalic Phase, Oncology Patients

Cephalic Phase of Oncology Patients Before and After Chemotherapy as Compared to Healthy Controls

Cephalic chemo
Start date: July 2007
Phase: N/A
Study type: Interventional

The objective of this trial is to examine the cephalic phase insulin response (CPIR) and pancreatic polypeptide (PP) release as indicators of the cephalic phase occurrence and magnitude to palatable food stimulus (chocolate cake) in oncology patients before and after chemotherapy treatment as compared to healthy controls . This may enlighten our understanding of the etiology of taste dysfunction and anorexia during chemotherapy treatments.

NCT ID: NCT00493519 Recruiting - Anorexia Nervosa Clinical Trials

Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters

Cephalic 1
Start date: July 2007
Phase: N/A
Study type: Interventional

The objective of this trial is to examine the cephalic phase insulin response (CPIR) and pancreatic polypeptide (PP) release as indicators of the cephalic phase occurrence and magnitude to palatable food stimulus in anorectic and bulimic subgroups as compared to healthy controls

NCT ID: NCT00492726 Completed - Infection Clinical Trials

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Start date: July 2006
Phase: Phase 3
Study type: Interventional

A study to compare the safety and efficacy of moxifloxacin to ertapenem in patients with intra-abdominal infections.

NCT ID: NCT00492154 Terminated - Forearm Injuries Clinical Trials

Fracture of Distal Radius and Ulna Healed With Shortening of One Bone. Clinical Significance at Skeletal Maturity

Start date: September 2008
Phase: N/A
Study type: Observational

The fractures of distal forearm are the most common trauma in children. Sometimes one of the bones becomes shortened as a result of fracture fragments overlap. When some amount of shortening exists, concern regarding relationship of distal radio-ulnar joint (DRUJ) arises. The common opinion is expressed in one of the textbooks and is represented by one sentence, which usually one bone shortening is well tolerated, probably does not cause a problem, and does not have clinical significance. However, pathology of ulna plus or minus variants is well described and may cause ulno-carpal abutting syndrome or radiocarpal pain. This concern may lead to more aggressive approach in treatment of a fracture, with attempts to make an equal bone length. We did not find in the literature study that investigates this problem. We postulate that obvious shortening of one bone may cause an inequality of DRUJ and can be clinically significant.

NCT ID: NCT00491634 Completed - Clinical trials for Acute Myeloid Leukemia

Treosulfan-based Conditioning for Transplantation in AML/MDS

Start date: June 2007
Phase: Phase 2
Study type: Interventional

The study hypotheses is that the introduction of dose escalated treosulfan, in substitution to busulfan, will reduce toxicity after allogeneic transplantation while improving myeloablation and and disease control in patients with AML and MDS not eligible for standard transplantation.

NCT ID: NCT00491491 Completed - Clinical trials for Non-Hodgkin's Lymphoma

Zevalin-beam for Aggressive Lymphoma

Start date: June 2007
Phase: Phase 3
Study type: Interventional

The study hypothesis is that the addition of zevalin radioimmunotherapy to the conditioning regimen given prior to BEAM high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive lymphoma will reduced disease recurrence rate and improve overall and disease-free survival.

NCT ID: NCT00491465 Not yet recruiting - Type 1 Diabetes Clinical Trials

The Role of Physical Activity in the Treatment of Children With Type 1 Diabetes.

4301
Start date: July 2007
Phase: N/A
Study type: Interventional

Randomized, controlled, open, comparative intervention study in two groups, each consisting of 25 children with type 1 diabetes that will undergo twelve weeks of exercise program (intensive arm) and twelve weeks of regular activity (non intensive arm) separated by four week of washout period. The study will be conducted in a crossover manner: one group starting with the intensive arm followed by the non intensive arm and vice versa. Blood glucose, HbA1C, Fructosamine, 3 days continuous glucose monitoring system (CGMS), total daily insulin dose, fasting lipid profile, body impedance and BMR will be measured. Self esteem and quality of life questionnaires will be filled.

NCT ID: NCT00491452 Completed - Clinical trials for Mitral Regurgitation

Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings

IMR2
Start date: April 2007
Phase: N/A
Study type: Observational

Mitral valve repair for ischemic mitral regurgitation is performed primarily by annuloplasty. There is some degree of late failure, which may be due in part to the type of ring employed. We want to compare late results with mitral valve annuloplasty using flexible vs rigid annuloplasty rings.